SINOPHARM(01099),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01099 SINOPHARM

Closed 01-21 16:08:56

20.700

+0.000

0.00%

High20.800	Low20.420	Vol4.91M
Open20.700	D1 Closing20.700	Amplitude1.84%
Mkt Cap64.60B	Tradable Cap27.78B	Total Shares3.12B
T/O101.09M	T/O Rate0.37%	Tradable Shares1.34B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01099","market":"HK","secType":"STK","nameCN":"SINOPHARM","latestPrice":20.7,"timestamp":1768982936002,"preClose":20.7,"halted":0,"volume":4908640,"delay":0,"changeRate":0,"floatShares":1341810740,"shares":3121000000,"eps":2.259128,"marketStatus":"Closed","change":0,"latestTime":"01-21 16:08:56","open":20.7,"high":20.8,"low":20.42,"amount":101094498,"amplitude":0.018357,"askPrice":20.7,"askSize":72800,"bidPrice":20.68,"bidSize":19200,"shortable":3,"etf":0,"ttmEps":2.479965,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1769045400000},"marketStatusCode":5,"adr":0,"listingDate":1253635200000,"exchange":"SEHK","adjPreClose":20.7,"dividendRate":0.03676,"openAndCloseTimeList":[[1768959000000,1768968000000],[1768971600000,1768982400000]],"volumeRatio":1.149863,"lotSize":400,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"SNP.HK","impliedVol":0.2497,"impliedVolPercentile":0.2642},"requestUrl":"/m/hq/s/01099/tweets","defaultTab":"tweets","newsList":[{"id":"2605117681","title":"China's Bank of China, China Construction Bank, China Mobile, Icbc, Sinopharm, Crrc, BYD Expected to Join - Sources","url":"https://stock-news.laohu8.com/highlight/detail?id=2605117681","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605117681?lang=en_us&edition=fundamental","pubTime":"2026-01-21 15:16","pubTimestamp":1768979791,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nP8N3XI08T:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1328615791.USD","LU2213484517.USD","01099","LU0633140727.USD","BK0015","LU0823413587.USD","LU0516423174.USD","LU0823397103.USD","LU1580142542.USD","600941","LU1115378108.SGD","LU2663582299.SGD","BK0187","BK0072","SG9999001226.SGD","601988","LU0823397285.USD","BK0183","601939","BK0155","002594","BK0070","LU0039217434.USD","SG9999001093.SGD","SGXZ81163826.USD","BK1500","LU2148510915.USD","LU0516423091.SGD","SG9999006597.SGD","LU1064131003.USD","SGXZ49509284.SGD","LU0516422366.SGD","BK0169","LU1146622755.USD","EVS.SI","BK0188","LU0683595622.HKD","LU1781817850.SGD","SG9999001051.SGD","BK0012","LU0823413660.USD","LU1064130708.USD","LU1508157978.USD","LU2360107325.USD","LU1997244956.HKD","LU1997245094.SGD","BK0028","LU0516422440.USD","LU0516422952.EUR","LU2580892862.HKD"],"gpt_icon":0},{"id":"2604894871","title":"Sinopharm Group  Stock Sheds 1.6% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2604894871","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604894871?lang=en_us&edition=fundamental","pubTime":"2026-01-19 16:32","pubTimestamp":1768811520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. shed 1.6% to 20.28 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.0% to 26563.90.Sinopharm Group Co. Ltd. closed 6.4% below its 52-week high of HK$21.66, which the company reached Nov. 14.Despite its losses, the stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. fell 2.4%.Trading volume totaled 5.4 million shares, compared to the 50-day average of 4.5 million shares.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0640798160.USD","BK1515","SHTDY","LU1115378108.SGD","BK4175","BK1197","01099","BK1500"],"gpt_icon":0},{"id":"2601873842","title":"Sinopharm Group  Stock Rallies 1.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2601873842","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601873842?lang=en_us&edition=fundamental","pubTime":"2026-01-07 16:32","pubTimestamp":1767774720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. advanced 1.9% to 20.44 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.9% to 26458.95.This was the stock's fifth consecutive day of gains.Sinopharm Group Co. Ltd. closed 5.6% below its 52-week high of HK$21.66, which the company achieved Nov. 14.The stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. fell 1.0%.Trading volume totaled 4.9 million shares, compared to the 50-day average of 4.4 million shares.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099","LU1115378108.SGD","BK4175","SHTDY","BK1500","BK1515","LU0640798160.USD","BK1197"],"gpt_icon":0},{"id":"2601807088","title":"Is Sinopharm Group (HKG:1099) A Risky Investment?","url":"https://stock-news.laohu8.com/highlight/detail?id=2601807088","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601807088?lang=en_us&edition=fundamental","pubTime":"2026-01-05 08:17","pubTimestamp":1767572249,"startTime":"0","endTime":"0","summary":"Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6031000-choice2-main-header/1585186857496","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6031000-choice2-main-header/1585186857496"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-1099/sinopharm-group-shares/news/is-sinopharm-group-hkg1099-a-risky-investment-5","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-1099/sinopharm-group-shares/news/is-sinopharm-group-hkg1099-a-risky-investment-5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0640798160.USD","BK1197","LU1115378108.SGD","01099","BK1515","EBIT","BK1500"],"gpt_icon":0},{"id":"2593420460","title":"Sinopharm Group  Stock Slides 0.8% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2593420460","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593420460?lang=en_us&edition=fundamental","pubTime":"2025-12-24 16:32","pubTimestamp":1766565120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. slumped 0.8% to 19.53 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.2% to 25818.93.Sinopharm Group Co. Ltd. closed 12% below its 52-week high of HK$22.25, which the company achieved Dec. 27.Despite its losses, the stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. fell 1.1%.Trading volume totaled 1.4 million shares, compared to the 50-day average of 4.6 million shares.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1197","01099","BK4175","BK1515","BK1500","LU0640798160.USD","SHTDY","LU1115378108.SGD"],"gpt_icon":0},{"id":"2593100179","title":"Sinopharm Group  Stock Sheds 1.1% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2593100179","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593100179?lang=en_us&edition=fundamental","pubTime":"2025-12-22 16:32","pubTimestamp":1766392320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. slipped 1.1% to 19.63 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.4% to 25801.77.The stock's fall snapped a three-day winning streak.Sinopharm Group Co. Ltd. closed 12% below its 52-week high of HK$22.30, which the company achieved Dec. 24.Despite its losses, the stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. fell 1.6%.Trading volume totaled 3.6 million shares, compared to the 50-day average of 4.8 million shares.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SHTDY","LU0640798160.USD","BK1197","BK1500","BK4175","01099","BK1515","LU1115378108.SGD"],"gpt_icon":0},{"id":"2592815739","title":"Sinopharm Group Files Director List with HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2592815739","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592815739?lang=en_us&edition=fundamental","pubTime":"2025-12-19 17:09","pubTimestamp":1766135398,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinopharm Group Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 19, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nNDLbpkmxK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0640798160.USD","BK1197","LU1115378108.SGD","01099","BK1515","BK1500"],"gpt_icon":0},{"id":"2592764975","title":"Sinopharm Group  Stock Climbs 0.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2592764975","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592764975?lang=en_us&edition=fundamental","pubTime":"2025-12-18 16:33","pubTimestamp":1766046780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. inched 0.9% higher to 19.79 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.1% to 25498.13.This was the stock's second consecutive day of gains.Sinopharm Group Co. Ltd. closed 11% short of its 52-week high of HK$22.30, which the company achieved Dec. 24.The stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 0.3%.Trading volume totaled 3.6 million shares, compared to the 50-day average of 4.8 million shares.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","01099","BK1500","LU1115378108.SGD","BK1197","BK4175","LU0640798160.USD","SHTDY"],"gpt_icon":0},{"id":"2591061918","title":"Sinopharm Group  Stock Slides 2.0% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2591061918","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591061918?lang=en_us&edition=fundamental","pubTime":"2025-12-15 16:33","pubTimestamp":1765787580,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. slipped 2.0% to 19.96 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.3% to 25628.88.The stock's fall snapped a two-day winning streak.Sinopharm Group Co. Ltd. closed 11% below its 52-week high of HK$22.35, which the company achieved Dec. 16.The stock underperformed when compared to some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. fell 0.7%.Trading volume totaled 5.1 million shares, compared to the 50-day average of 4.7 million shares.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0640798160.USD","BK1197","LU1115378108.SGD","BK1515","BK1500","BK4175","01099","SHTDY"],"gpt_icon":0},{"id":"2591577662","title":"Sinopharm Group (SEHK:1099): Valuation Check After Renewing Shanghai Henlius Distribution Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2591577662","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591577662?lang=en_us&edition=fundamental","pubTime":"2025-12-14 23:15","pubTimestamp":1765725346,"startTime":"0","endTime":"0","summary":"Sinopharm Group (SEHK:1099) is back in focus after Shanghai Henlius Biotech moved to renew their long running distribution framework, extending Sinopharm’s role in distributing Henlius products from 2026 through 2028.\nSee our latest analysis for Sinopharm Group.\nThe renewed Henlius deal lands while Sinopharm’s HK$20.36 share price has seen a modest 1 day share price return of 1.09% but a softer 30 day share price return of 4.77%, with a more reassuring 5 year total shareholder return of...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6031000-choice2-main-header/1585186857496","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6031000-choice2-main-header/1585186857496"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-1099/sinopharm-group-shares/news/sinopharm-group-sehk1099-valuation-check-after-renewing-shan","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-1099/sinopharm-group-shares/news/sinopharm-group-sehk1099-valuation-check-after-renewing-shan","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","LU0640798160.USD","LU1115378108.SGD","BK1515","BK1197","01099","BK1500"],"gpt_icon":0},{"id":"2590144521","title":"How Investors Are Reacting To Sinopharm Group (SEHK:1099) Extending Its Henlius Distribution Framework Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2590144521","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590144521?lang=en_us&edition=fundamental","pubTime":"2025-12-12 07:31","pubTimestamp":1765495880,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech previously announced it would renew and extend its Sinopharm Distribution Framework Agreement, keeping Sinopharm Group as a key distributor of certain Henlius products from 2026 to 2028, with potential automatic renewal subject to Hong Kong Listing Rules.\nAlongside this continued commercial collaboration, upcoming board and committee changes at Sinopharm Group highlight an evolving governance setup that investors may watch closely.\nWe’ll now examine how the extended...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6031000-choice2-main-header/1585186857496","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6031000-choice2-main-header/1585186857496"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-1099/sinopharm-group-shares/news/how-investors-are-reacting-to-sinopharm-group-sehk1099-exten","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-1099/sinopharm-group-shares/news/how-investors-are-reacting-to-sinopharm-group-sehk1099-exten","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1115378108.SGD","BK1500","01099","ISBC","BK4211","BK1197","BK1515","LU0640798160.USD"],"gpt_icon":0},{"id":"2590595603","title":"Sinopharm Group  Stock Rallies 0.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2590595603","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590595603?lang=en_us&edition=fundamental","pubTime":"2025-12-11 16:33","pubTimestamp":1765441980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. inched 0.9% higher to 20.14 Hong Kong dollars , on what proved to be an all-around mediocre trading session for the Hong Kong stock market, with the Hang Seng Index remaining mostly flat at 25530.51.The stock's rise snapped a three-day losing streak.Sinopharm Group Co. Ltd. closed 9.9% short of its 52-week high of HK$22.35, which the company achieved Dec. 16.The stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. fell 0.1%.Trading volume totaled 2.4 million shares, compared to the 50-day average of 4.8 million shares.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1115378108.SGD","BK1515","BK1500","BK4175","BK1197","01099","LU0640798160.USD","SHTDY"],"gpt_icon":0},{"id":"2590537697","title":"Sinopharm Group Co. Ltd. (HKG:1099) most popular amongst private companies who own 57% of the shares, institutions hold 28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590537697","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590537697?lang=en_us&edition=fundamental","pubTime":"2025-12-10 07:09","pubTimestamp":1765321758,"startTime":"0","endTime":"0","summary":"Key Insights Sinopharm Group's significant private companies ownership suggests that the key decisions are influenced...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6031000-choice2-main-header/1585186857496","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6031000-choice2-main-header/1585186857496"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-1099/sinopharm-group-shares/news/sinopharm-group-co-ltd-hkg1099-most-popular-amongst-private","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-1099/sinopharm-group-shares/news/sinopharm-group-co-ltd-hkg1099-most-popular-amongst-private","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["01099","LU1115378108.SGD","BK1197","BK1500","LU0640798160.USD","BK1515"],"gpt_icon":0},{"id":"2590331694","title":"Sinopharm Group  Stock Slides 1.6% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2590331694","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590331694?lang=en_us&edition=fundamental","pubTime":"2025-12-09 16:33","pubTimestamp":1765269180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. slid 1.6% to 20.04 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.3% to 25434.23.This was the stock's second consecutive day of losses.Sinopharm Group Co. Ltd. closed 10% below its 52-week high of HK$22.35, which the company reached Dec. 16.The stock underperformed when compared to some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 0.9%.Trading volume totaled 3.5 million shares, compared to the 50-day average of 4.9 million shares.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099","BK1515","BK1500","BK4175","LU1115378108.SGD","SHTDY","LU0640798160.USD","BK1197"],"gpt_icon":0},{"id":"1185295246","title":"Sinopharm (01099) Announces November 2025 Share Capital Data","url":"https://stock-news.laohu8.com/highlight/detail?id=1185295246","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185295246?lang=en_us&edition=fundamental","pubTime":"2025-12-04 17:05","pubTimestamp":1764839109,"startTime":"0","endTime":"0","summary":"Sinopharm (01099) reported that, as of November 30, 2025, its total authorized/registered share capital remained RMB 3,120,656,191. The company’s H Shares and Domestic Shares stood unchanged at...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"gpt_icon":0},{"id":"1104227863","title":"Sinopharm Group (01099) Announces Director Appointments and Schedules EGM","url":"https://stock-news.laohu8.com/highlight/detail?id=1104227863","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104227863?lang=en_us&edition=fundamental","pubTime":"2025-12-04 06:24","pubTimestamp":1764800668,"startTime":"0","endTime":"0","summary":"Sinopharm Group Co. Ltd. (01099) has released a circular announcing proposed appointments of non-executive and executive directors. The appointments will be voted on at an Extraordinary General...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"gpt_icon":0},{"id":"2588002221","title":"Sinopharm Group Co. Ltd. Announces Date for Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2588002221","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588002221?lang=en_us&edition=fundamental","pubTime":"2025-12-04 06:12","pubTimestamp":1764799966,"startTime":"0","endTime":"0","summary":"Sinopharm Group Co. Ltd. will hold an extraordinary general meeting on December 19, 2025, at its Sinopharm Group Building in Shanghai, China. During the meeting, shareholders will consider and vote on the appointment of Mr. Jin Bin as a non-executive Director of the sixth session of the Board, with authorization for the Board to determine his remuneration and for the Chairman or any executive Director to enter into a service contract or related agreements with him. Additionally, the appointment of Ms. Li Ying as a non-executive Director of the sixth session of the Board will be considered, along with similar authorization for the Board regarding her remuneration and service contract arrangements.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nNDL2df6g0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1197","LU0640798160.USD","BK1515","LU1115378108.SGD","BK1500","01099"],"gpt_icon":0},{"id":"2588474037","title":"Sinopharm Group  Stock Advances 2.0% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2588474037","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588474037?lang=en_us&edition=fundamental","pubTime":"2025-12-01 16:32","pubTimestamp":1764577920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. rose 2.0% to 20.44 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.7% to 26033.26.The stock's rise snapped a two-day losing streak.Sinopharm Group Co. Ltd. closed 8.5% below its 52-week high of HK$22.35, which the company reached Dec. 16.The stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 1.9%.Trading volume totaled 4.7 million shares, compared to the 50-day average of 5.3 million shares.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","01099","LU1115378108.SGD","LU0640798160.USD","BK1515","BK1500","SHTDY","BK1197"],"gpt_icon":0},{"id":"1172022187","title":"SINOPHARM (01099) Proposes Appointment of Jin Bin and Li Ying as Non-Executive Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=1172022187","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172022187?lang=en_us&edition=fundamental","pubTime":"2025-11-28 22:54","pubTimestamp":1764341658,"startTime":"0","endTime":"0","summary":"SINOPHARM (01099) announced that due to work arrangements, Mr. Zhao Bingxiang has resigned from his positions as Non-Executive Director, Chairman of the Board, Chairman of the Nomination Committee,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099","BK1515","LU1115378108.SGD","BK1500","LU0640798160.USD","BK1197"],"gpt_icon":0},{"id":"1192028604","title":"Sinopharm Group Announces Changes to Board, Committees, and Meeting Schedule","url":"https://stock-news.laohu8.com/highlight/detail?id=1192028604","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192028604?lang=en_us&edition=fundamental","pubTime":"2025-11-28 22:41","pubTimestamp":1764340899,"startTime":"0","endTime":"0","summary":"Sinopharm Group Co. Ltd. (hereinafter referred to as Sinopharm Group) announced on 28 November 2025 a series of proposed changes in its board composition and key leadership roles. Non-executive...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinopharmgroup.com.cn","stockEarnings":[{"period":"1week","weight":0.0029},{"period":"1month","weight":0.0428},{"period":"3month","weight":0.0605},{"period":"6month","weight":0.0692},{"period":"1year","weight":0.0796},{"period":"ytd","weight":0.0648}],"compareEarnings":[{"period":"1week","weight":-0.0134},{"period":"1month","weight":0.031},{"period":"3month","weight":0.0274},{"period":"6month","weight":0.032},{"period":"1year","weight":0.3293},{"period":"ytd","weight":0.0334}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Sinopharm Group Co Ltd is a China-based company principally engaged in the wholesale and retail of pharmaceutical and healthcare products and medical devices. The Company operates its business through four segments. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services to domestic and foreign pharmaceutical and health product manufacturers and other suppliers. The Device Distribution segment distributes medical devices to customers. The Pharmaceutical Retail Business segment owns a network of retail pharmacies that are directly operated or franchised. The Other Business segment is engaged in the manufacture and sale of pharmaceuticals, chemical reagents and laboratory supplies.","yearOnYearQuotes":[{"month":1,"riseRate":0.588235,"avgChangeRate":0.004098},{"month":2,"riseRate":0.5625,"avgChangeRate":0.030473},{"month":3,"riseRate":0.5,"avgChangeRate":0.010225},{"month":4,"riseRate":0.4375,"avgChangeRate":0.022869},{"month":5,"riseRate":0.625,"avgChangeRate":-0.004548},{"month":6,"riseRate":0.4375,"avgChangeRate":-0.005852},{"month":7,"riseRate":0.5,"avgChangeRate":-0.015111},{"month":8,"riseRate":0.4375,"avgChangeRate":0.012101},{"month":9,"riseRate":0.4375,"avgChangeRate":-0.011177},{"month":10,"riseRate":0.647059,"avgChangeRate":0.042295},{"month":11,"riseRate":0.470588,"avgChangeRate":-0.007287},{"month":12,"riseRate":0.529412,"avgChangeRate":-0.004122}],"exchange":"SEHK","name":"SINOPHARM","nameEN":"SINOPHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SINOPHARM(01099),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SINOPHARM(01099) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SINOPHARM,01099,SINOPHARM股票,SINOPHARM股票老虎,SINOPHARM股票老虎国际,SINOPHARM行情,SINOPHARM股票行情,SINOPHARM股价,SINOPHARM股市,SINOPHARM股票价格,SINOPHARM股票交易,SINOPHARM股票购买,SINOPHARM股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SINOPHARM(01099),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SINOPHARM(01099) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}